26 Programs
-
Optimizing Biomarker Assessment and Related Treatment Decision-Making for Patients with HR-Positive Metastatic Breast Cancer
-
-
S
-
S
-
-
S
-
S
-
-
Key Presentations from the 2025 American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia
-
-
P
-
P
-
-
P
-
P
-
-
Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia
-
-
B
-
B
-
-
B
-
B
-
-
Optimal Management of Squamous Cell Carcinoma of the Anal Canal
-
-
M
-
M
-
-
M
-
M
-